Terms ending in 2026
Every in-force patent on Teleflex Life Sciences LLC's record whose computed term ends in 2026, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 7,595,429 | Calcium Zeolite Hemostatic Agent In force · Medium confidence | Teleflex Life Sciences II LLC | In force | Medium confidence | |
| US 8,252,344 | Partially Hydrated Hemostatic Agent In force · Medium confidence | Teleflex Life Sciences II LLC | In force | Medium confidence | |
| US 7,968,114 | Clay-Based Hemostatic Agents and Devices for the Delivery Thereof In force · High confidence | Teleflex Life Sciences II LLC | In force | High confidence | |
| US 8,007,503 | Apparatus and Method for Manipulating or Retracting Tissue and Anatomical Structure In force · High confidence | Teleflex Life Sciences LLC | In force | High confidence | |
| US 7,594,509 | Heat and Moisture Exchange Device for Respiratory Therapy In force · High confidence | Teleflex Life Sciences LLC | In force | High confidence |
5 of 5 patents shown. Soonest term end first, then patent number.
Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.